ReachSci Ventures
Empowering Research-Driven Innovation
ReachSci Ventures is a specialized incubator dedicated to supporting science and research-driven startups on their journey from groundbreaking ideas to market success. We bring together global talent, expert mentorship, and strategic resources to help innovators transform academic and scientific research into impactful ventures.
Our Support Programme
At ReachSci Ventures, we provide comprehensive support tailored to the unique needs of research-driven startups. Our current programme includes:
Personalized Mentorship
One-on-one feedback and guidance from industry experts and seasoned entrepreneurs
Global Innovation Network
Access to a community of like-minded innovators and researchers from across the globe
Collaborative Learning
Regular group workshops and structured feedback sessions to refine your business model and strategy
Investment Readiness Support
Strategic preparation and connections for fundraising opportunities (initiated based on startup readiness, typically beginning June-July)
Additional resources and support mechanisms are introduced as startups progress through their development journey.
Building Global Innovation Capacity
ReachSci Ventures is committed to building global capacity in research commercialization and deep tech innovation. Our mission is to bridge the gap between scientific discovery and market application by nurturing entrepreneurs with the skills, connections, and confidence to succeed.
Current Portfolio
We are currently supporting seven innovative startups from six countries, representing cutting-edge solutions across various scientific and technological domains.
For investors interested in learning more about our portfolio companies, please contact the ReachSci founder directly. Startup-specific inquiries can be directed to respective company CEOs.
Note: ReachSci Ventures operates on an invitation-only basis and is not currently accepting unsolicited applications.
Utano Hypertension Solutions
CEO Name: Elvis Chiboyiwa
CEO WhatsApp: +263 77 5572 231
CEO Email: elvischiboyiwa@gmail.com
Start-Up Bio
Approximately 1.6 million (27%) Zimbabweans are suffering from hypertension. About 75% do not adhere to recommended diet because of prohibitive costs and unavailability of healthy foods. Our solution is a nutritious low sodium food bar made from natural, wholesome local ingredients to help control and manage hypertension. Existing alternatives are expensive, have high sodium content, are seasonal and unhealthy. Our USP is “Bite healthy, chew healthy, swallow healthy, stay healthy”. Our team has an expert in public health, a biochemist, a finance expert and a marketing and business administration expert. This year we plan to conduct all the laboratory work, get all the registrations and start mass production.
Investment Ask & Milestones
We are kindly looking for an initial investment of $23,540 which we intend to use for initial set-up and production (First 3 Months). This investment will be channeled towards registrations, laboratory work, labor, equipment rentals, packaging, marketing and raw material procurement. Our planned output for this reporting period is 1500kg which translates to 40,500 bars. We intend to make a profit of $146,963 by end of financial year 1 and $572,889 by end of financial year 3. So far, MVP production, standardisation and initial research has been completed. Mass production, marketing and distribution will start by October 2025.
ReachFood
CEO Name: Amera Otoum
CEO WhatsApp: +962792977610
CEO Email: Ameraaloto@gmail.com
Start-Up Bio
There is a significant gap in access to convenient, nutritious, and culturally appropriate meals in the MENA region, especially for children, working women, students, travelers, and people in conflict zones. Current competitors lack solutions that suit fast-paced lifestyles, support recovery, or offer sustainable packaging. Our solution is the first culturally tailored, nutritious, ready-to-eat meal in MENA requiring no preparation, accessible anywhere, and packaged in eco-friendly, seedable, reusable materials free of bioplastics. It also takes into account individual access needs. Led by a multidisciplinary team under ReachSci Society, we aim to pilot in Saudi Arabia and launch production this year.
Investment Ask & Milestones
Q2 (Apr–Jun): Completed prototype, business, product, and market plans; secured packaging partners; food partnership and tracking plan ongoing; patent and website in progress.
Q3 (Jul–Sep): Finalize R&D, obtain certifications, begin production, and distribute initial batch
Initial investment of $40,000 covers production $16,000, staffing $6,500, operations $5,000, marketing $4,000, logistics and certifications $3,000 each, and R&D $2,500. This budget supports key milestones including testing, approvals, and pilot launch, paving the way for customer validation and future fundraising Q4 OF 2025
NBIO INDONESIA
CEO Name: Wening Rahayu
CEO WhatsApp: +62877-4969-6943
CEO Email: nbioindo@gmail.com
Start-up Bio
NBIO INDONESIA is a startup focused on developing biochar and organic fertilizer products from biomass waste. We offer innovative solutions to improve soil fertility and reduce environmental impact. With pyrolysis technology and nanopore development innovation, we produce high-quality products that can save up to 3 times agricultural production costs, benefiting farmers and plantation industries. Unlike competitors, we excel in utilizing local biomass waste and environmentally friendly production processes. We plan to increase our production capacity and distribution this year."
Investment Proposal & Milestones
We are seeking an investment of USD 333,857.75 with a 15% profit share, estimated net profit of USD 38,866,667/year, to boost our production capacity and distribution. The funds will be used to acquire advanced production equipment and expand our distribution network. With this investment, we aim to increase sales to 1000 tons/day and become a market leader in biochar and organic fertilizer products in Indonesia and the Asia Pacific region. We believe our startup has significant growth potential and look forward to partnering with the right investors to achieve our goals.
Viva
CEO Name: Dr. Zainab Al-Araji
CEO WhatsApp: +9647717788029
CEO Email: viva2025iq@gmail.com
Start-Up Bio
Viva is an Iraqi pharmaceutical skincare startup addressing the widespread use of unregulated and ineffective skin products. Viva offers custom-made, medically supervised skincare solutions based on each individual's needs. Every formula is uniquely compounded after consultation, with follow-ups to track results. Unlike generic cosmetic brands, Viva provides science-based treatments and continuous care. With over 10 years of pharmaceutical expertise, proven success in Iraq, France, and the UAE, and with zero paid marketing, Viva stands out with trust and personalization. This year, we aim to launch our official website and expand nationwide through pharmacy networks.
Investment Ask & Milestones
We are seeking an investment of $30,000 – $50,000 to support our next phase of growth. This funding will enable us to:
- Launch Viva’s official website with integrated consultation and order systems
- Expand our digital marketing strategy to reach new customers across Iraq
- Scale up production capacity and upgrade our formulation equipment
- Build partnerships with trusted pharmacy chains nationwide
- Reach 250 regular customers by early 2026
We offer a high-trust, low-cost, and scalable solution in a rapidly growing market undersereved by personalized skincare.
ProBreeder
CEO Name: Randa Elayyan
CEO WhatsApp: +962785332426
CEO Email: randa.elayyan@probreeder.com
Start-up bio
ProBreeder addresses the lack of efficient, data-driven tools for animal breeders to manage health and nutrition records. Our mobile app simplifies tracking vaccinations, treatments, feeding schedules, and breeding cycles, providing actionable insights and alerts. Unlike traditional pen-and-paper or scattered apps, ProBreeder offers an integrated solution tailored to breeders’ daily needs. Our main competitors focus narrowly on pet care or farm management; our USP is precision breeding support with health and nutrition analytics. Our team combines agricultural and tech expertise, with domain knowledge and development skills. This year, we aim to launch MVP, onboard 100+ breeders, and start regional scaling.
Investment Proposal & Milestones
We’re seeking $100,000 in pre-seed funding to finalize product development, run pilot programs, and execute go-to-market campaigns. Key milestones: complete MVP by Q2, pilot with 5 large breeders and 100+ animals by Q3, and launch publicly by Q4. Value inflection points include successful pilot metrics, user retention, and data partnerships. By year-end, we aim to validate our revenue model and prepare for seed-stage fundraising.
NPIMCS
CEO Name: NOURHAN HESHAM
CEO WhatsApp: +96878477931
CEO Email: 75521609@uofn.edu.om
Start-Up Bio
NPIMCS is a pharmaceutical startup revolutionizing drug delivery with ultra-fast dissolving sublingual films. These films address the widespread issue of patients struggling to swallow tablets, which leads to poor medication adherence and delayed treatment. By dissolving instantly under the tongue, the films enable rapid absorption and improved bioavailability. Backed by funding from the Oman Research Council and the University of Nizwa, NPIMCS has advanced to preclinical testing and bioequivalence studies. With a pending patent and recognition from the Cambridge Hackathon, NPIMCS aims to deliver patient-friendly, fast-acting treatments that enhance global health outcomes.
Investment Proposal & Milestones
We are seeking \$150,000–\$250,000 in funding to support key development milestones, including essential animal studies, lab setup, and core team salaries. The investment will also fund bioequivalence testing between our patented natural formulation and existing drugs, complete patent registration, and advance regulatory approval. Our value lies in a novel, fast-absorbing natural drug delivery system that addresses patient needs and improves treatment outcomes. With a clear regulatory path and strong market demand for effective, patient-friendly alternatives, this funding will position NPIMCS for clinical advancement and future commercialization in the global pharmaceutical market.
Protein Hive
CEO Name: Olivia Naliaka
CEO WhatsApp: +254727264125
CEO Email: olivia.simiyu77@gmail.com
Start-Up Bio
We are a sustainable insect production company revolutionizing access to affordable, protein-rich food and feed in Kenya. With rising food insecurity and environmental strain from traditional livestock, our solution harnesses crickets and mealworms—nutrient-dense, eco-friendly alternatives. Starting operations this year, we produce premium insect-based products for human and animal consumption. Our competitive edge lies in local sourcing, vertical farming, cold chain storage, and expert-led R&D. Backed by a dynamic team of agricultural scientists, food technologists, and innovators, we’re building a scalable model that nourishes communities, regenerates the planet, and meets the growing demand for healthier, sustainable protein options.
Investment Proposal & Milestones
With $150,000, we will complete facility setup, begin full-scale production, develop branded products, and secure key distribution channels. Milestones include pilot sales (Month 2), retail launch (Month 4), and breaking even (Month 9). Key inflection points: product-market fit, strategic partnerships, and recurring revenue from both insect products and farmer subscriptions.